Intellectual Property Litigation at the International Trade Commission (ITC) – Moderated Discussion [Subtitles]
2022/9/26
Latest trends and case studies in FDA compliance – Moderated Discussion [Subtitles]
2022/9/26
Covington & Burling LLP
![Latest trends and case studies in FDA compliance [subtitles]](https://legal.fronteo.com/fllp/wp-content/uploads/2022/09/cov_038_cover.png)
In this video, Covington Partner Scott Cunningham gives an overview of the firm's FDA regulatory practice and uses case studies to showcase recent trends and developments, including how the FDA responds to and adapts to new technologies such as mobile phone Apps that operate as a medical device.
Only members can watch it.
Please refrain from registering at a law firm, in the same industry as our company, or with a free email address.
Covington & Burling LLP
Subtitles are machine translated, not provided by a law firm
In this video, Covington Partner Scott Cunningham gives an overview of the firm's FDA regulatory practice and uses case studies to showcase recent trends and developments, including how the FDA responds to and adapts to new technologies such as mobile phone Apps that operate as a medical device.
Scott Cunningham
Partners
![Latest trends and case studies in FDA compliance [subtitles]](https://legal.fronteo.com/fllp/wp-content/uploads/2022/09/Cunningham_Scott_s.png)
Scott Cunningham is a member of Covington's Food and Drug practice group. He represents pharmaceutical, biotechnology, and medical device companies as well as trade associations in matters before the FDA, Congress, state and federal courts, and other regulatory and enforcement agencies. Scott has significant experience in areas including new product development and clinical trials; IRBs; new product approvals; Hatch-Waxman exclusivities and product life-cycle management; advertising and promotion; False Claims Act and Anti-Kickback compliance issues and pharmaceutical investigations; Orphan Drug; pediatric exclusivity; manufacturing and cGMPs; import/export; controlled substances; SEC disclosure; and other aspects of federal and state regulation of pharmaceuticals, biologics, and medical devices.
Scott also has an active pro bono practice where he regularly serves as a Guardian ad Litem representing children in neglect & abuse and child custody cases.
Profile
Covington & Burling LLP
![Latest trends and case studies in FDA compliance [subtitles]](https://legal.fronteo.com/fllp/wp-content/uploads/2020/05/COVINGTON_logo.png){kind=logo}
Covington Burling LLP was founded in Washington, DC in 1919 and currently has 13 offices worldwide. With over 1,200 internationally renowned and professional lawyers, our responsiveness to provide outstanding legal services and strategic advice is highly regarded. With over 100 senior government officials, he is not only familiar with the fields of corporate law, litigation and investigation, but also his deep insight into policy and policy makers and the quality of comprehensive regulatory advisory services. The height has a good reputation all over the world.
It has been selected as one of the "100 Global Elites Selected by GCR" many times in the past from the Global Competition Review, and has been selected as one of the world's top 2015 antitrust laws every year from 19 to 20.In addition to being repeatedly named on the "A List" by American Lawyers, he has been ranked in the Top 25 in the US in the General Counseling category of Americas Best Corporate Law Firm by Corporate Board Members.
We have as clients many Japanese companies, trade organizations, and government agencies, and through the Japan Department, we are working to further deepen our relationship with Japan and respond to more accurate needs.
Inquiry
If you have any questions or concerns regarding the content or materials, please feel free to contact us.We would also appreciate it if you could request a topic you would like to hear. (Both Japanese and English are acceptable)
